Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Sep 1;100(5):1199–1203. doi: 10.1172/JCI119632

The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.

M Takada 1, A Chandraker 1, K C Nadeau 1, M H Sayegh 1, N L Tilney 1
PMCID: PMC508296  PMID: 9276737

Abstract

Ischemia/reperfusion injury associated with organ retrieval and storage influences the development of chronic graft dysfunction, the major clinical problem in solid organ transplantation. The potential role of mononuclear cells (T cells and monocyte/macrophages) in this type of injury is unknown. Inbred male Lewis rats were uninephrectomized and the left kidney perfused in situ with 10 ml of iced University of Wisconsin solution. Immunohistological studies showed mononuclear cell infiltration of the ischemic organs associated with the upregulation of MHC class II antigen expression. Reverse transcriptase-PCR indicated that T cell associated cytokines and monocyte/macrophage activation markers/products are upregulated early after the ischemic insult. B7 expression occurred within 24 h and peaked at 3 d. Plasma creatinine levels rose transiently with complete recovery of renal function by 5 d. Animals began to develop progressive proteinuria after 8-12 wk, indicative of the long-term functional consequences of early ischemia/reperfusion injury. Blockade of T cell CD28-B7 costimulation with CTLA4Ig resulted in significant inhibition of T cell and macrophage infiltration and activation in situ. Treated animals did not exhibit transient renal dysfunction, nor developed proteinuria over time. This is the first demonstration that blocking T cell costimulatory activation in the absence of alloantigen can prevent the early and late consequences of ischemia/reperfusion injury.

Full Text

The Full Text of this article is available as a PDF (163.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azuma H., Chandraker A., Nadeau K., Hancock W. W., Carpenter C. B., Tilney N. L., Sayegh M. H. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12439–12444. doi: 10.1073/pnas.93.22.12439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carpenter C. B. Long-term failure of renal transplants: adding insult to injury. Kidney Int Suppl. 1995 Aug;50:S40–S44. [PubMed] [Google Scholar]
  3. Chandraker A., Russell M. E., Glysing-Jensen T., Willett T. A., Sayegh M. H. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen. Transplantation. 1997 Apr 27;63(8):1053–1058. doi: 10.1097/00007890-199704270-00002. [DOI] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Dempsey J. A. Sleep apnea causes daytime hypertension. J Clin Invest. 1997 Jan 1;99(1):1–2. doi: 10.1172/JCI119119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goes N., Urmson J., Ramassar V., Halloran P. F. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation. 1995 Feb 27;59(4):565–572. [PubMed] [Google Scholar]
  7. Halloran P. F., Urmson J., Van der Meide P. H., Autenried P. Regulation of MHC expression in vivo. II. IFN-alpha/beta inducers and recombinant IFN-alpha modulate MHC antigen expression in mouse tissues. J Immunol. 1989 Jun 15;142(12):4241–4247. [PubMed] [Google Scholar]
  8. Hancock W. W., Lord R. H., Colby A. J., Diamantstein T., Rickles F. R., Dijkstra C., Hogg N., Tilney N. L. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol. 1987 Jan 1;138(1):164–170. [PubMed] [Google Scholar]
  9. Kelly K. J., Williams W. W., Jr, Colvin R. B., Bonventre J. V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):812–816. doi: 10.1073/pnas.91.2.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lenschow D. J., Zeng Y., Thistlethwaite J. R., Montag A., Brady W., Gibson M. G., Linsley P. S., Bluestone J. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 7;257(5071):789–792. doi: 10.1126/science.1323143. [DOI] [PubMed] [Google Scholar]
  11. Linsley P. S., Clark E. A., Ledbetter J. A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5031–5035. doi: 10.1073/pnas.87.13.5031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Linsley P. S., Wallace P. M., Johnson J., Gibson M. G., Greene J. L., Ledbetter J. A., Singh C., Tepper M. A. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 1992 Aug 7;257(5071):792–795. doi: 10.1126/science.1496399. [DOI] [PubMed] [Google Scholar]
  13. Nadeau K. C., Azuma H., Tilney N. L. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8729–8733. doi: 10.1073/pnas.92.19.8729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pearson T. C., Alexander D. Z., Winn K. J., Linsley P. S., Lowry R. P., Larsen C. P. Transplantation tolerance induced by CTLA4-Ig. Transplantation. 1994 Jun 27;57(12):1701–1706. [PubMed] [Google Scholar]
  15. Perico N., Imberti O., Bontempelli M., Remuzzi G. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig. Kidney Int. 1995 Jan;47(1):241–246. doi: 10.1038/ki.1995.30. [DOI] [PubMed] [Google Scholar]
  16. Platzer C., Ode-Hakim S., Reinke P., Döcke W. D., Ewert R., Volk H. D. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation. 1994 Jul 27;58(2):264–268. [PubMed] [Google Scholar]
  17. Russell M. E., Hancock W. W., Akalin E., Wallace A. F., Glysing-Jensen T., Willett T. A., Sayegh M. H. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest. 1996 Feb 1;97(3):833–838. doi: 10.1172/JCI118483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Russell M. E., Wallace A. F., Hancock W. W., Sayegh M. H., Adams D. H., Sibinga N. E., Wyner L. R., Karnovsky M. J. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 1995 Feb 27;59(4):572–578. [PubMed] [Google Scholar]
  19. Russell M. E., Wallace A. F., Wyner L. R., Newell J. B., Karnovsky M. J. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 1995 Aug 1;92(3):457–464. doi: 10.1161/01.cir.92.3.457. [DOI] [PubMed] [Google Scholar]
  20. Sayegh M. H., Akalin E., Hancock W. W., Russell M. E., Carpenter C. B., Linsley P. S., Turka L. A. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med. 1995 May 1;181(5):1869–1874. doi: 10.1084/jem.181.5.1869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sayegh M. H., Turka L. A. T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol. 1995 Oct;6(4):1143–1150. doi: 10.1681/ASN.V641143. [DOI] [PubMed] [Google Scholar]
  22. Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990 Oct 18;347(6294):669–671. doi: 10.1038/347669a0. [DOI] [PubMed] [Google Scholar]
  23. Schwartz R. H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 1992 Dec 24;71(7):1065–1068. doi: 10.1016/s0092-8674(05)80055-8. [DOI] [PubMed] [Google Scholar]
  24. Sharma V. K., Bologa R. M., Xu G. P., Li B., Mouradian J., Wang J., Serur D., Rao V., Suthanthiran M. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int. 1996 May;49(5):1297–1303. doi: 10.1038/ki.1996.185. [DOI] [PubMed] [Google Scholar]
  25. Tan P., Anasetti C., Hansen J. A., Melrose J., Brunvand M., Bradshaw J., Ledbetter J. A., Linsley P. S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med. 1993 Jan 1;177(1):165–173. doi: 10.1084/jem.177.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tullius S. G., Tilney N. L. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation. 1995 Feb 15;59(3):313–318. [PubMed] [Google Scholar]
  27. Turcovski-Corrales S. M., Fenton R. G., Peltz G., Taub D. D. CD28:B7 interactions promote T cell adhesion. Eur J Immunol. 1995 Nov;25(11):3087–3093. doi: 10.1002/eji.1830251115. [DOI] [PubMed] [Google Scholar]
  28. Turka L. A., Linsley P. S., Lin H., Brady W., Leiden J. M., Wei R. Q., Gibson M. L., Zheng X. G., Myrdal S., Gordon D. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):11102–11105. doi: 10.1073/pnas.89.22.11102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yamamoto T., Noble N. A., Miller D. E., Border W. A. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int. 1994 Mar;45(3):916–927. doi: 10.1038/ki.1994.122. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES